Trump's tariffs could squeeze US factories and boost costs by up to 4.5%, a new analysis finds
'There's going to be a cash squeeze for a lot of these firms,' said Chris Bangert-Drowns, the researcher at the Washington Center for Equitable Growth who conducted the analysis. Those seemingly small changes at factories with slim profit margins, Bangert-Drowns said, 'could lead to stagnation of wages, if not layoffs and closures of plants" if the costs are untenable.
The analysis, released Tuesday, points to the challenges Trump might face in trying to sell his tariffs to the public as a broader political and economic win and not just as evidence his negotiating style gets other nations to back down. The success of Trump's policies ultimately depends on whether everyday Americans become wealthier and factory towns experience revivals, a goal outside economists say his Republican administration is unlikely to meet with tariffs.
Trump has announced new frameworks with the European Union, Japan, the Philippines, Indonesia and Britain that would each raise the import taxes charged by the United States. He's prepared to levy tariffs against goods from dozens of other countries starting on Friday in the stated range of 15% to 50%.
The U.S. stock market has shown relief the tariff rates aren't as high as Trump initially threatened in April and hope for a sense of stability going forward. Trump maintains the tariff revenues will whittle down the budget deficit and help whip up domestic factory jobs, all while playing down the risks of higher prices.
'We've wiped out inflation," Trump said last Friday before boarding Marine One while on his way to Scotland.
But there's the possibility of backlash in the form of higher prices and slower growth once tariffs flow more fully through the world economy.
A June survey by the Atlanta Federal Reserve suggested companies would on average pass half of their tariff costs onto U.S. consumers through higher prices. Labor Department data shows America lost 14,000 manufacturing jobs after Trump rolled out his April tariffs, putting a lot of pressure as to whether a rebound starts in the June employment report coming out Friday.
With new tariffs in place, there are new costs for factories
The Washington Center for Equitable Growth analysis shows how Trump's devotion to tariffs carries potential economic and political costs for his agenda. In the swing states of Michigan and Wisconsin, more than 1 in 5 jobs are in the critical sectors of manufacturing, construction, mining and oil drilling and maintenance that have high exposures to his import taxes.
The artificial intelligence sector Trump last week touted as the future of the economy is dependent on imports. More than 20% of the inputs for computer and electronics manufacturing are imported, so the tariffs could ultimately magnify a hefty multitrillion-dollar price tag for building out the technology in the U.S.
The White House argues American businesses will access new markets because of the trade frameworks, saying companies will ultimately benefit as a result.
'The 'Made in USA' label is set to resume its global dominance under President Trump,' White House spokesman Kush Desai said.
Still lots of uncertainty, but world economy faces a new toll
There are limits to the analysis. Trump's tariff rates have been a moving target, and the analysis looks only at additional costs, not how those costs will be absorbed among foreign producers, domestic manufacturers and consumers. Also, the legal basis of the tariffs as an 'emergency' act goes before a U.S. appeals court on Thursday.
Treasury Secretary Scott Bessent said in an interview last week on Fox Business Network's 'Kudlow" show countries were essentially accepting the tariffs to maintain access to the U.S. market. 'Everyone is willing to pay a toll,' he said.
But what Bessent didn't say is U.S. manufacturers are also paying much of that toll.
'We're getting squeezed from all sides,'' said Justin Johnson, president of Jordan Manufacturing Co. in Belding, Michigan, northeast of Grand Rapids. His grandfather founded the company in 1949.
The company, which makes parts used by Amazon warehouses, auto companies and aerospace firms, has seen the price of a key raw material — steel coil — rise 5% to 10% this year.
Trump has imposed 50% tariffs on imported steel and aluminum. Jordan Manufacturing doesn't buy foreign steel. But by crippling foreign competition, Trump's tariffs have allowed domestic U.S. steelmakers to hike prices.
Johnson doesn't blame them. 'There's no red-blooded capitalist who isn't going to raise his prices'' under those circumstances, he said.
Trump says no inflation from tariffs, but businesses see higher prices
The Trump White House insists inflation is not surfacing in the economy, issuing a report through the Council of Economic Advisers this month saying the price of imported goods fell between December of last year and this past May. 'These findings contradict claims that tariffs or tariff-fears would lead to an acceleration of inflation,' the report concludes.
Ernie Tedeschi, director of economics at the Budget Lab at Yale University, said that the more accurate measure would be to compare the trends in import prices with themselves in the past and that the CEA's own numbers show 'import prices have accelerated in recent months.'
The latest estimate from the Budget Lab at Yale is the tariffs would cause the average household to have $2,400 less than it would otherwise have.
Keeping the economy on a knife's edge
Josh Smith, founder and president of Montana Knife Co., called himself a Trump voter but said he sees the tariffs on foreign steel and other goods as threatening his business.
For instance, Smith just ordered a $515,000 machine from Germany that grinds his knife blades to a sharp edge. Trump had imposed a 10% tax on products from the EU that is set to rise to 15% under the trade framework he announced Sunday. So Trump's tax on the machine comes to $77,250 — about enough for Smith to hire an entry-level worker.
Smith would happily buy the bevel-grinding machines from an American supplier. But there aren't any. 'There's only two companies in the world that make them, and they're both in Germany,'' Smith said.
Then there's imported steel, which Trump is taxing at 50%. Until this year, Montana Knife bought the powdered steel it needs from Crucible Industries in Syracuse, New York. But Crucible declared bankruptcy last December, and its assets were purchased by a Swedish firm, Erasteel, which moved production to Sweden.
Smith beat the tariffs by buying a year's worth of the steel in advance. But starting in 2026, the specialty steel he'll be importing from Sweden is set to be hit with a 50% duty.
'The average American is not sitting in the position I am, looking at the numbers I am and making the decisions each day, like, 'Hey, we cannot hire those extra few people because we might have to pay this tariff on this steel or this tariff on this grinder,''' he said. 'I want to buy more equipment and hire more people. That's what I want to do.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Brachytherapy Devices Market is Growing at CAGR of 6.7% During 2025 -2031 to Reach US$534.20 Million
NEW YORK, Aug 4, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the Brachytherapy Devices Market is witnessing significant growth due to the rising incidence of cancer worldwide and technological advancements in brachytherapy devices. The Brachytherapy Devices Market value is expected to reach US$534.20 million by 2031 from US$343.57 million in 2024; the market is anticipated to register a CAGR of 6.7% during 2025–2031. The market growth is attributed to the rising incidence of cancer worldwide, the aging population, and the technological advancements in brachytherapy devices. The Brachytherapy Devices Market analysis focuses on advancements such as MRI-compatible applicators and real-time imaging integration that play a vital role in the market growth. The report runs an in-depth analysis of market trends, key players, and future opportunities. Check valuable insights in the Brachytherapy Devices Market report. You can easily get a sample PDF of the report - Overview of Brachytherapy Devices Market Report Findings Rising Incidence of Cancer Worldwide:As per the GLOBOCAN 2020 report, more than 28.4 million new cancer cases are expected to be reported by 2040. An aging population, lack of physical activity, exposure to pollutants in the environment, and alterations in diet lead to increased rates of an internal radiation treatment, is ideal for the treatment of prostate, cervical, breast, and skin cancers. It allows for the radiation to be targeted directly to the tumor and avoid the surrounding healthy tissues, with reduced side effects and improved recovery times. Thus, brachytherapy is becoming increasingly popular among oncologists and cancer remains among the major causes of mortality globally, demand for effective, low-invasive, and affordable treatment procedures is rising. Brachytherapy is meeting this demand, particularly in facilities where it might not be possible to access highly advanced external radiation facilities. Thus, the increasing burden of cancers worldwide propels the market growth. Technological Advancements in Brachytherapy Devices:Advances in the area are improving the accuracy, safety, and effectiveness of treatments, making brachytherapy a progressively appealing choice for cancer technological advancements include the creation of high-dose rate (HDR) and low-dose rate (LDR) machines, which provide more accurate radiation delivery. HDR machines provide for administering higher doses of radiation in shorter times, making treatment faster and more convenient for patients. MRI-compatible applicators and integration of sophisticated imaging are providing better tumor localization and online monitoring of treatment. These advances allow clinicians to target tumors effectively with less exposure to healthy tissues in the proximity. The robot-assisted platforms provide higher accuracy and precision, particularly in challenging anatomical areas. In addition, miniaturization and mobility of brachytherapy equipment are facilitating treatments, especially in developing advances in technology are making brachytherapy more effective and safer but and increasing its uses in treating a broader spectrum of cancers. Consequently, the greater uptake of these machines is contributing to their adoption and setting the limits of cancer treatment even higher. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR during the forecast period. Stay Updated on Brachytherapy Devices Market Trends: Brachytherapy Devices Market Segmentation Based on product, the Brachytherapy Devices Market is segmented into seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy. The brachytherapy afterloaders segment held the largest market share in 2024. In terms of type, the Brachytherapy Devices Market is categorized into high-dose rate brachytherapy implant and low-dose rate brachytherapy implant. The low-dose rate brachytherapy implant segment dominated the market in 2024. By application, the Brachytherapy Devices Market is segmented into breast cancer, cervical cancer, prostate cancer, lung cancer, and others. The prostate cancer segment dominated the market in 2024. Per end user, the Brachytherapy Devices Market is divided into hospitals and specialty clinics, ambulatory surgical centers, and others. The hospitals and specialty clinics segment dominated the market in 2024. The Brachytherapy Devices Market is segmented into five major regions: North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. Competitive Strategy and Development Key players: Elekta, Varian Medical Systems, Inc., BEBIG Medical, Theragenics Corporation, IsoAid, Siemens Healthineers AG, BXTA, BD, and Eckert and Ziegler are among the major companies operating in the Brachytherapy Devices Market. Trending topics: Advancements in Imaging Technologies, Government Initiatives and Cancer Treatment Programs, Technological Advancements in Brachytherapy Devices, Integration of Artificial Intelligence (AI) and Robotics in brachytherapy, etc. Headlines on Brachytherapy Devices Market Artemis Hospital Announces the Launch of Brachytherapy Services, Expanding Advanced Cancer Care Papua New Guinea Resumes Radiotherapy, Starts Brachytherapy Services with IAEA Support BEBIG Medical Launches SagiNova Brachytherapy System at Father Muller Hospital as a Part of New Healthcare Wing Medanta Patents MAOLO Brachytherapy Device For Advanced Cervical Cancer Treatment Elekta Expands Brachytherapy Portfolio With Acquisition of iCad Inc.'s Xoft Business CivaTech Oncology Receives FDA Approval for CivaSheet Brachytherapy Device Get Premium Copy of Brachytherapy Devices Market Size and Growth Report by 2031 at: Conclusion The growth of the Brachytherapy Devices Market is fueled by the increasing prevalence of cancer, advances in technology, and soaring demand for minimally invasive treatment options. The high-dose rate (HDR) systems, MRI-compatible applicators, and robotic-assisted devices are increasing the accuracy of treatment and speeding up patient recovery. Further, there is a growing demand for affordable and patient-centric therapies, particularly in areas that have poor access to conventional cancer therapy. With increasing uses in prostate, breast, and cervical cancers, the demand for brachytherapy is surging, with better results and accessibility in cancer therapy. The report from The Insight Partners provides several stakeholders—including manufacturers of seeds, brachytherapy afterloaders and applicators, and electronic brachytherapy devices—with valuable insights to navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: Brachytherapy After Loaders Market Strategies, Top Players, Growth Opportunities, Analysis and Forecast by 2031 Cancer Therapy Market Scope, Share, and Size by 2031 Pancreatic Cancer Therapy Market SWOT Analysis by 2031 Lung Cancer Therapy Market Research Report by 2030 Cancer Biopsies Market Trends, Share, and Growth – 2031 Cervical Cancer Diagnostics and Therapeutics Market Size 2031 Kidney Cancer Therapeutics And Diagnostics Market Size 2031 Cancer Biopsies Market Trends, Share, and Growth - 2031 Thyroid Cancer Diagnostics Market Growth and Share by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials. Contact Us:If you have any queries about this report or if you would like further information, please get in touch with us:Contact Person: Ankit MathurE-mail: +1-646-491-9876 Logo: View original content: SOURCE The Insight Partners Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
3 minutes ago
- Yahoo
Michigan State football loses recruiting staff member to Nevada
A familiar face in the recruiting department has departed Michigan State for a new position in the college football world. Austin D'Armond has left his role with Michigan State to become the Director of Player Personnel & Recruiting Strategy at Nevada. During his time at MSU, he held the role of Director of Player Personnel/Defense working on the Spartans recruiting efforts on the defensive side of the ball. Prior to joining Jonathan Smith and company in East Lansing, D'Armond was a member of Smith's staff in Corvallis at Oregon State for two seasons in a similar recruiting role. Getting an undergraduate and graduate degrees from Texas, D'Armond spent two years as a recruiting intern, and upon graduating, he became a player personnel graduate assistant for the Longhorns. Michigan State has already filled some of the void he left, adding Michael Morales from Texas to the staff, and there is an expectation that the Spartans could be making one or two more hires in it's recruiting department, that is led by Director of Recruiting and Player Relations, Michael Doctor. Contact/Follow us @The SpartansWire on X (formerly Twitter) and like our page on Facebook to follow ongoing coverage of Michigan State news, notes and opinion. You can also follow Cory Linsner on X @Cory_Linsner This article originally appeared on Spartans Wire: Michigan State football loses member of recruiting staff
Yahoo
3 minutes ago
- Yahoo
Fmr. Commerce Sec. Wilbur Ross explains Trump's BLS suspicions
Tariffs on countries like Japan and Switzerland remain in place as Trump pushes to improve the US trade balance. Wilbur Ross, former US Commerce Secretary, joins Opening Bid to discuss trade policy and prospects for a China deal. To watch more expert insights and analysis on the latest market action, check out more Opening Bid. So what's next on the trade deal front? Want to welcome back onto Opening Bid, longtime investor Wilbur Ross. Mr. Ross served as the U.S. Commerce Secretary in President Trump's first term and has had a close relationship with the president for decades. Mr. Secretary, always nice to get some time with you. Appreciate you coming on here. Um, before we get into the topic of trade, I'm sure you've seen what's been going on, uh, with the president, uh, dismissing or firing the BLS commissioner. You know, you're a longtime investor. Do you still believe that the economic data coming out of the government? Well, I think what is a little bit suspicious about the most recent BLS data is it came out shortly after the Fed FOMC meeting where Trump was hoping to get rates reduced. And clearly, if the two big revisions had come out before the meeting, it would have been more likely that the FOMC would cut rates. And that's the second time that that sort of suspicious behavior occurred. Remember, just before the presidential election, they also had two months of very good, uh, labor results, and then a day or two after the election, they made a massive correction in both months. Again, had that been out before the election, it would have been helpful to Trump. So, I can understand why he would be suspicious at least of the timing as to whether the underlying data themselves are correct. I I would really have no way to know. But it is a little spooky that there were two recent events, big numbers, big changes, uh, that could have helped Trump, had they been more timely. Do you believe, uh, Mr. Secretary, uh, before we get into the trade, I, like the president, noted on Friday after the numbers were hit, that this data is rigged, not only the jobs data, but perhaps other data that the government provides? Well, I think that's just speculation. Um, I certainly never tried to influence the data that came out of the Bureau of Economic Analysis, which is part of Department of Commerce. We never had any problems like that during my term. But we also never had the kinds of events that I just described to you that naturally make one a little suspicious. Mr. Secretary, on the on the trade front, um, since we last talked, tariffs have stayed in place for many countries. I mentioned Japan at 15%, Switzerland now at 39%. Are tariffs the new normal for the duration of the president's, uh, second term here in your view? Or is there an opportunity to take these 15% tariff rates that that Japan is now paying and negotiate them down further? Well, I think the president has made clear that if there are further reductions by other countries, that he would take that into account. So, his target is really improving our balance of trade. That's one of his major objectives. And that can either be done by holding back the trade of foreign countries through tariffs or by everybody cutting it together. So, I think trade policy will continue to be a centerpiece of his administration, but that doesn't mean everything will be increasing. What gets, uh, a deal with China over the finish line? Well, China, as you know, is going to be having their big party Congress very, very shortly. And, as you may know, I've felt for some time that it was unlikely that they would make a radical change in policy before the Party Congress. They don't normally do that. And, uh, I think that Congress is either this week or next week. So, we should know pretty soon if anything different will come out of that. But certainly, the news that was out today about the critical materials, uh, being still restricted, that was not very encouraging. Uh, Mr. Secretary, the fact that China has not solidified a deal with the U.S. on trade, is it likely then that its tariff rate will be higher than what we saw, uh, from the likes of Japan and, of course, the European Union? Well, it's up pretty high right now. And it's, um, I I don't know whether he would make it even higher, but, you know, once you get to about 30 or so percent on the tariffs, it doesn't make too much difference if you go beyond because 30 odd percent is very, very hard for a country to absorb. And as a result, 30 or so percent is the demarcation between are you going to be doing trade with them or not. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data